Dernières nouvelles pour Twist Bioscience (NASDAQ:TWST) Stock

Twist Bioscience

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Twist Bioscience Corporation - Common Stock

Twist Bioscience Corp

Flowserve (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLS#NYSE">FLS</a>) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.60 by 20 percent. This is a 24.14 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $1.15 billion which beat the analyst consensus estimate of $1.11 billion by 3.16 percent. This is a 5.34 percent increase over sales of $1.09 billion the same period last year.

Earnings

Earnings Beats

News

Flowserve Q1 Adj. EPS $0.72 Beats $0.60 Estimate, Sales $1.15B Beat $1.11B Estimate

Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) is looking for Q4 Adj EPS of $2.20-$2.60 vs $2.20 analyst estimate. sees sales of $2.250 billion-$2.550 billion vs $2.43 billion analyst estimate.

Guidance

Seagate Tech Hldgs Sees Q4 Adj EPS $2.20-$2.60 vs $2.20 Est; Sees Sales $2.250B-$2.550B vs $2.43B Est

Benchmark Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHE#NYSE">BHE</a>) is looking for Q2 GAAP EPS of $0.31-$0.37 vs $0.39 analyst estimate..

Benchmark Electronics Sees Q2 GAAP EPS $0.31-$0.37 vs $0.39 Est

WIIM

BKNG

Booking Holdings shares are trading lower. The stock may be moving in sympathy with Trivago, which reported Q1 financial results and missed its revenue estimate.

Benchmark Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHE#NYSE">BHE</a>) is looking for Q2 Adj EPS of $0.52-$0.58 vs $0.53 analyst estimate. sees sales of $615.000 million-$665.000 million vs $666.58 million analyst estimate.

Benchmark Electronics Sees Q2 Adj EPS $0.52-$0.58 vs $0.53 Est; Sees Sales $615.000M-$665.000M vs $666.58M Est

Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) could highlight its progress in artificial intelligence when it reports first-quarter financial results after <a href="https://www.benzinga.com/earnings">market close Wednesday.</a>
Here are the analyst earnings estimates, what experts are saying ahead of the report and key items to watch.
Earnings Estimates: Analysts expect Meta Platforms to report first-quarter revenue of $41.39 billion. That&#8217;s up from $36.45 billion, according to data <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429">from Benzinga Pro.</a>
The social media and technology company has beaten analyst estimates for revenue in 10 straight quarters.
Analysts expect the company to report first-quarter earnings per share of $5.28, up from $4.71 in last year's first quarter. The company has beaten analyst estimates for earnings per share in eight straight quarters.
Previous<a href="https://www.benzinga.com/general/social-media/25/01/43322201/meta-platforms-q4-earnings-revenue-beat-eps-beat-daily-actives-up-5-continued-strong-revenue-growth-expected"> guidance from the company</a> calls for first-quarter revenue to be in a range of $39.5 billion to $41.8 billion.
Read Also: <a href="https://www.benzinga.com/25/04/45065712/meta-q1-earnings-on-deck-expert-sees-growth-at-a-reasonable-price">Meta Q1 Earnings On Deck: Expert Sees Growth At A &#8216;Reasonable Price&#8217;</a>
What Experts Are Saying: With the potential of downward revisions to fiscal 2025 guidance for revenues, margins, EPS and free cash flow, Needham analyst Laura Martin recently reiterated an Underperform rating on Meta Platforms.
Martin said there is also concern that there could be upward revisions to capital expenditures and losses at the company's Reality Labs division. Her estimate for first-quarter revenue is $40.5 billion and earnings per share of $4.82. Both figures are below the analyst consensus estimates.
Meta CEO Mark Zuckerberg testified in the FTC antitrust trial that the amount of time people spend on Facebook and Instagram has "gone down meaningfully,&#8221; Martin recalled.
Freedom Capital Markets Chief Global Strategist Jay Woods <a href="https://jaywoods.substack.com/">said </a>the key questions ahead of earnings revolve around advertising spending by Chinese companies, AI initiatives and their contribution to growth and how much time daily active users are spending on Meta's platforms.
"Meta shares are 26% below their 52-week highs and currently embroiled in litigation which has taken CEO Mark Zuckerberg away from his daily activities," Woods said.
Here are other recent <a href="https://www.benzinga.com/quote/META/analyst-ratings">analyst ratings on Meta Platforms</a> and their price targets:
<ul>
<li>Loop Capital: Maintained Buy rating, lowered price target from $900 to $695</li>
<li>Stifel: Maintained Buy rating, lowered price target from $740 to $628</li>
<li>Benchmark: Maintained Buy rating, lowered price target from $820 to $640</li>
<li>Scotiabank: Maintained Sector Perform rating, lowered price target from $627 to $525</li>
<li>Morgan Stanley: Maintained Overweight rating, lowered price target from $660 to $615</li>
</ul>
Key Items to Watch: Meta likely won't discuss its <a href="https://www.benzinga.com/general/social-media/25/04/44799581/no-expiration-date-on-metas-antitrust-case-says-former-ftc-chair-ahead-of-trial">ongoing antitrust litigation</a>. Still, commentary on growth or usage of Instagram and WhatsApp could provide key given these segments could be forced to be spun out from the company in the future.
In the fourth quarter, total revenue was up 21% year-over-year for the company. Investors and analysts will be looking for some of the positive momentum to continue in the first quarter in areas like daily active users, ad impressions and average price per ad.
With the macroeconomic environment and tariff concerns, there is the possibility that Meta Platforms saw lower advertising demand.
Costs and expenses will be another key topic with a recent report saying the company <a href="https://www.benzinga.com/markets/25/04/45004229/mark-zuckerbergs-meta-lays-off-unspecified-number-of-employees-at-its-reality-labs-division-report">was laying off people </a>from its Reality Labs division, on top of a large company-wide headcount reduction in February.
Progress with AI initiatives is likely to be a large focus from investors and analysts in the company commentary and during the earnings call.
"We continue to make good progress on AI, glasses and the future of social media. I'm excited to see these efforts scale further in 2025," Zuckerberg said after fourth-quarter results. &nbsp;
On Tuesday, Meta <a href="https://about.fb.com/news/2025/04/introducing-meta-ai-app-new-way-access-ai-assistant/">hosted </a>its first ever Gen-AI developer conference called LlamaCon. Among the highlights of the event was the introduction of AI assistant Meta AI, which could be a ChatGPT competitor with a standalone app.
"We're launching the first version of the Meta AI app: the assistant that gets to know your preferences, remembers context and is personalized to you," the company said.
Meta AI is being used across all Meta platforms. The launch of a standalone AI app will likely be a highlight for the company and could be a focus in Wednesday's commentary.
META Price Action: Meta Platforms stock is up 0.3% to $551.25 on Tuesday versus a 52-week trading range of $427.20 to $740.89. Meta stock is down 8.1% year-to-date and up 27.3% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45037345/microsoft-meta-amazon-apple-gear-up-for-ai-revolution-week-as-tariff-storm-brews">Microsoft, Meta, Amazon, Apple Gear Up For &#8216;AI Revolution&#8217; Week As Tariff Storm Brews</a></li>
</ul>
Image: Shutterstock

Analyst Color

Social Media

Previews

Reiteration

Analyst Ratings

Tech

Trading Ideas

Meta Platforms Q1 Earnings Preview: Analyst Expects Weak Guidance, Will Company Continue Streak Of Revenue Beats?

Ranger Energy Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNGR#NYSE">RNGR</a>) reported quarterly earnings of $0.03 per share. This is a 200 percent increase over losses of $(0.03) per share from the same period last year. The company reported $135.20 million in sales this quarter. This is a 1.24 percent decrease over sales of $136.90 million the same period last year.

RNGR

Ranger Energy Services Q1 EPS $0.03 Up From $(0.03) YoY, Sales $135.20M Down From $136.90M YoY

LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.05 by 140 percent. This is a 125 percent decrease over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $143.43 million which beat the analyst consensus estimate of $133.66 million by 7.31 percent. This is a 3.78 percent increase over sales of $138.20 million the same period last year.

Earnings Misses

LSB Industries Q1 GAAP EPS $(0.02) Misses $0.05 Estimate, Sales $143.43M Beat $133.66M Estimate

Rosenblatt analyst Barton Crockett initiated coverage on Magnite, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNI#NASDAQ">MGNI</a>) with a Buy rating <a href="https://www.benzinga.com/quote/MGNI/analyst-ratings" target="_blank" rel="noreferrer noopener">and a price forecast of $18</a>.
The analyst wrote on Monday that despite navigating Google&#8216;s anti-competitive practices, Magnite has achieved healthy double-digit to mid-teens average growth in the five years since the Rubicon-Telaria merger.
The analyst believes Magnite&#8217;s potential is even greater if regulatory actions level the playing field with Google.
Crockett says that Magnite is well-positioned to capitalize on the ongoing shift from traditional TV to Connected TV (CTV) and the expansion of programmatic advertising.
Notably, the analyst expects macroeconomic concerns to lessen after the 2026 midterms as President Donald Trump potentially moderates disruptive economic measures.
The analyst estimates 2025 revenue of $747 million (vs. consensus of $750 million) and adjusted EPS of $0.72 (vs. street view of $0.94).
For 2026, Crockett estimates revenue of $819 million (vs. consensus of $838 million) and adjusted EPS of $0.85 compared to consensus of $1.20.
The company plans to release its financial results for the first quarter after the <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">market closes on May 7, 2025</a>.
Investors can gain exposure to the stock via&nbsp;Elevation Series Trust Clough Select Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBSE#NYSE">CBSE</a>) and KraneShares Trust KraneShares Man Buyout Beta Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUYO#NYSE">BUYO</a>).
Price Action: MGNI shares were down 0.4% to $12.30 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/44633754" target="_blank" rel="noreferrer noopener">Stagwell Stock Could Outperform With 12% Growth, But Analyst Warns Of Market Skepticism Amid Macro Concerns</a></li>
</ul>
Photo: Shutterstock

Equities

Initiation

Small Cap

Movers

KraneShares Trust KraneShares Man Buyout Beta Index ETF

BUYO

Changebridge Capital Sustainable Equity ETF

CBSE

MGNI

Magnite's Growth Prospects Strengthen As CTV, Regulation Shift In Its Favor

Sage Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) reported quarterly losses of $(1.01) per share which missed the analyst consensus estimate of $(0.99) by 2.02 percent. This is a 43.89 percent increase over losses of $(1.80) per share from the same period last year. The company reported quarterly sales of $14.06 million which met the analyst consensus estimate. This is a 77.97 percent increase over sales of $7.90 million the same period last year.

SAGE

Sage Therapeutics Q1 EPS $(1.01) Misses $(0.99) Estimate, Sales $14.06M Inline

Benchmark Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHE#NYSE">BHE</a>) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.48 by 8.33 percent. This is a 5.45 percent decrease over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $631.76 million which missed the analyst consensus estimate of $640.00 million by 1.29 percent. This is a 6.48 percent decrease over sales of $675.58 million the same period last year.

Benchmark Electronics Q1 Adj. EPS $0.52 Beats $0.48 Estimate, Sales $631.76M Miss $640.00M Estimate

SNAP

Snap Announces It Doesn't Intend to Share Formal Financial Guidance for 2Q, Cites Uncertainty Of Macro Economic Conditions

Cushion's technology to complement and enhance LendingClub's suite of mobile financial products and experiences&nbsp;
SAN FRANCISCO, April 29, 2025 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4416170-1&amp;h=323518881&amp;u=https%3A%2F%2Fwww.lendingclub.com%2F&amp;a=LendingClub+Corporation">LendingClub Corporation</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>), America's leading digital marketplace bank, today announced the acquisition of intellectual property and select talent behind Cushion, an AI-powered spending intelligence platform, providing a natural complement to LendingClub's suite of mobile financial products and experiences.

LendingClub Acquires Intellectual Property And Select Talent Behind Cushion; Financial Terms Not Disclosed

W.P. Carey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPC#NYSE">WPC</a>) affirms FY2025 FFO guidance from $4.82-$4.92 to $4.82-$4.92 vs $4.87 analyst estimate..

W.P. Carey Affirms FY2025 FFO Guidance of $4.82-$4.92 vs $4.87 Est

ODDITY Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) raises FY2025 Adj EPS guidance from $1.94-$1.98 to $1.99-$2.04 vs $1.93 analyst estimate. Raises FY2025 sales outlook from $776.00 million-$785.00 million to $790.00 million-$798.00 million vs $784.10 million estimate.

ODDITY Tech Raises FY2025 Adj EPS Guidance from $1.94-$1.98 to $1.99-$2.04 vs $1.93 Est; Raises FY2025 Sales Guidance from $776.00M-$785.00M to $790.00M-$798.00M vs $784.10M Est

ODDITY Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) is looking for Q2 Adj EPS of $0.85-$0.89 vs $0.84 analyst estimate. sees sales of $235.000 million-$239.000 million vs $232.54 million analyst estimate.

ODDITY Tech Sees Q2 Adj EPS $0.85-$0.89 vs $0.84 Est; Sees Sales $235.000M-$239.000M vs $232.54M Est

Stag Industrial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STAG#NYSE">STAG</a>) reported quarterly earnings of $0.61 per share which beat the analyst consensus estimate of $0.60 by 1.67 percent. This is a 3.39 percent increase over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $205.57 million which beat the analyst consensus estimate of $201.11 million by 2.22 percent. This is a 9.61 percent increase over sales of $187.54 million the same period last year.

STAG

Stag Industrial Q1 FFO $0.61 Beats $0.60 Estimate, Sales $205.57M Beat $201.11M Estimate

Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.08) by 37.5 percent. This is a 88.3 percent increase over losses of $(0.94) per share from the same period last year. The company reported quarterly sales of $1.77 million which missed the analyst consensus estimate of $1.80 million by 1.25 percent. This is a 56.94 percent increase over sales of $1.13 million the same period last year.

INTZ

Intrusion Q1 EPS $(0.11) Misses $(0.08) Estimate, Sales $1.77M Miss $1.80M Estimate

Zynex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) Q2 expected to be more than $(0.20) vs $(0.12) Est. Q2 Revenue expected to be more than $27.00M vs $33.75M Est

Comments

Twist Bioscience

Actualités

Dernières nouvelles pour Twist Bioscience (NASDAQ:TWST) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL